Mohsin Naqvi left the ground without handing over the Women’s Asia Cup Trophy to India. His tenure as Asian Cricket Council (ACC) president will come to an end in April 2027, and he is unlikely to be selected as the new president for the forthcoming term, given the controversial things that have been happening due to the bitter relationship between India and Pakistan.
Mohsin Naqvi has once again been under the radar of controversy, as he appeared during the Women’s Asia Cup 2026 final between the India Women’s National Cricket Team and the Sri Lanka Women’s National Cricket Team at the Dubai International Stadium in Dubai. Harmanpreet Kaur’s side refused to take the trophy from the ACC president, citing the cold relationship.
Mohsin Naqvi unlikely to get new term as ACC chairman
As per reports from PTI, Mohsin Naqvi's tenure as chairman of the ACC ends in April 2027, which is roughly another 7 months. There is a provision for extension, but an extension for him is unlikely to happen, as he will not get a vote of support from the rest of the board members.
As of now, BCCI is also unlikely to do anything; it is believed that Naqvi certainly will not get another term, and he won't get any support from other ACC members, due to the worsening of the relationship between India and Pakistan, which has affected the reputation of the ACC.
MORE TO FOLLOW....
Hence then, the article about mohsin naqvi unlikely to get another term as acc chairman after asia cup trophy controversy was published today ( ) and is available on cricketaddictor ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Mohsin Naqvi unlikely to get another term as ACC chairman after Asia Cup trophy controversy )
Also on site :
- Walmart’s ‘Vintage-Style’ $15 Cordless Milk Glass Lamp Has All the Retro Charm of an Antique Store Find
- The Trump Family’s Ireland Trip: From a Bathroom Mirror Selfie with the President to Twinning with Don Jr.
- Johnson & Johnson's RYBREVANT® (amivantamab-vmjw) plus chemotherapy delivers longest reported median overall survival in EGFR exon 20 insertion mutation-positive lung cancer